MENU
+Compare
LLY
Stock ticker: NYSE
AS OF
Sep 3, 04:59 PM (EDT)
Price
$737.66
Change
+$2.47 (+0.34%)
Capitalization
659.07B

LLY Eli Lilly & Co Forecast, Technical & Fundamental Analysis

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology... Show more

LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LLY with price predictions
Sep 02, 2025

LLY in upward trend: price expected to rise as it breaks its lower Bollinger Band on August 07, 2025

LLY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 31 cases where LLY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where LLY's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 21, 2025. You may want to consider a long position or call options on LLY as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LLY just turned positive on August 19, 2025. Looking at past instances where LLY's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LLY advanced for three days, in of 371 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

LLY moved below its 50-day moving average on July 29, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LLY crossed bearishly below the 50-day moving average on August 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LLY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LLY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (36.101) is normal, around the industry mean (9.469). LLY has a moderately high P/E Ratio (48.052) as compared to the industry average of (23.843). Projected Growth (PEG Ratio) (0.805) is also within normal values, averaging (1.759). LLY has a moderately low Dividend Yield (0.008) as compared to the industry average of (0.027). LLY's P/S Ratio (12.453) is very high in comparison to the industry average of (3.421).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LLY is expected to report earnings to $6.36 per share on October 30

Eli Lilly & Co LLY Stock Earnings Reports
Q3'25
Est.
$6.36
Q2'25
Beat
by $0.72
Q1'25
Missed
by $0.12
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.27
The last earnings report on August 07 showed earnings per share of $6.31, beating the estimate of $5.59. With 459.98K shares outstanding, the current market capitalization sits at 659.07B.
A.I.Advisor
published Dividends

LLY is expected to pay dividends on September 10, 2025

Eli Lilly & Co LLY Stock Dividends
A dividend of $1.50 per share will be paid with a record date of September 10, 2025, and an ex-dividend date of August 15, 2025. The last dividend of $1.50 was paid on June 10. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Lilly Corporate Center
Phone
+1 317 276-2000
Employees
43000
Web
https://www.lilly.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FTAIN25.310.06
+0.24%
FTAI Aviation Ltd
ALFUU10.59N/A
N/A
Centurion Acquisition Corp
MESA1.23-0.01
-0.81%
Mesa Air Group
CLBK14.83-0.20
-1.33%
Columbia Financial
ALT3.75-0.08
-2.09%
Altimmune

LLY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with AZN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
+0.36%
AZN - LLY
41%
Loosely correlated
+0.36%
BIIB - LLY
37%
Loosely correlated
+5.60%
OGN - LLY
35%
Loosely correlated
N/A
MRK - LLY
33%
Poorly correlated
+1.62%
PFE - LLY
31%
Poorly correlated
+0.89%
More